Skip to content

Clinical trials

Lymphoma, T-Cell, Peripheral trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Country / region: South Korea Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20091
20121
20131
20152
20164
20181
20192
20202
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status3
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center3
AstraZeneca2
Chonnam National University Hospital2
Solasia Pharma K.K.2
Acrotech Biopharma Inc.1
Affimed GmbH1
Associazione Angela Serra per la ricerca sul cancro1
Boryung Pharmaceutical Co., Ltd1
Daiichi Sankyo1
Dizal Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral22
Recurrence4
Lymphoma, Extranodal NK-T-Cell3
Lymphoma2
Lymphoma, Non-Hodgkin2
Lymphoma, T-Cell2
Enteropathy-Associated T-Cell Lymphoma1
Febrile Neutropenia1
Hodgkin Disease1
Immunoblastic Lymphadenopathy1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.